Patient blood management in elective total hip- And knee-replacement surgery (Part 1): A randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients

Anesthesiology

Volumn 120, Issue 4, 2014, Pages 839-851

  So Osman, Cynthia ^a   Nelissen, Rob G H H ^b   Van Gemert, Ankie W M M Koopman ^c   Kluyver, Ewoud ^d   Pöll, Ruud G ^d,e   Onstenk, Ron ^f   Van Hilten, Joost A ^a   Jansen Werkhoven, Thekla M ^b   Van Den Hout, Wilbert B ^b   Brand, Ronald ^b   Brand, Anneke ^a,b  

^a CENTRAL LABORATORY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^d SLOTERVAART HOSPITAL   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f GROENE HART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS FUMARATE; HEMOGLOBIN; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT ERYTHROPOIETIN; ERYTHROPOIETIN;

ADULT; AGED; ALLERGY; ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD FILTER; BLOOD PRESSURE FLUCTUATION; BLOOD SALVAGE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; ECONOMIC EVALUATION; ERYTHROCYTE TRANSFUSION; FACTORIAL DESIGN; FEMALE; HEALTH CARE COST; HEART ARRHYTHMIA; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HIP ARTHROPLASTY; HIP DISLOCATION; HIP PROSTHESIS; HUMAN; INTRAOPERATIVE PERIOD; KNEE DISEASE; KNEE FRACTURE; KNEE PROSTHESIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DEVICE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS INFECTION; RANDOMIZED CONTROLLED TRIAL; RISK; SEPSIS; STATISTICAL ANALYSIS; THROMBOEMBOLISM; TOTAL KNEE REPLACEMENT; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; WOUND INFECTION; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DOUBLE BLIND PROCEDURE; ECONOMICS; ELECTIVE SURGERY; EQUIPMENT; KNEE ARTHROPLASTY; METHODOLOGY; MULTICENTER STUDY; NETHERLANDS; POSTOPERATIVE CARE; WOUND DRAINAGE;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION, AUTOLOGOUS; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; DRAINAGE; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; NETHERLANDS; ODDS RATIO; OPERATIVE BLOOD SALVAGE; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME;

EID: 84901812962     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000134     Document Type: Article

References (39)

1. Goodnough LT, Shander A: Patient blood management. Anesthesiology 2012; 116:1367-76.
2. Thomas D, Wareham K, Cohen D, Hutchings H: Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 2001; 86:669-73.
3. Shenolikar A, Wareham K, Newington D, Thomas D, Hughes J, Downes M: Cell salvage auto transfusion in total knee replacement surgery. Transfus Med 1997; 7:277-80.
4. Heddle NM, Brox WT, Klama LN, Dickson LL, Levine MN: A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion 1992; 32:742-6.
5. Slagis SV, Benjamin JB, Volz RG, Giordano GF: Postoperative blood salvage in total hip and knee arthroplasty. A randomised controlled trial. J Bone Joint Surg Br 1991; 73:591-4.
6. Huët C, Salmi LR, Fergusson D, Koopman-van-Gemert AW, Rubens F, Laupacis A: A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1999; 89:861-9.
7. Hill SR, Carless PA, Henry DA, Carson JL, Hebert PC, McClelland DB, Henderson KM: Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2002:CD002042.
8. Weber EW, Slappendel R, Hémon Y, Mähler S, Dalén T, Rouwet E, van Os J, Vosmaer A, van der Ark P: Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: The European Epoetin Alfa Surgery Trial (EE ST). Eur J Anaesthesiol 2005; 22:249-57.
9. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA: Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010:CD001888.
10. Rock G, Berger R, Bormanis J, Giulivi A, ElSaadany S, Afzal M, Beard J, Neurath D, Jones TG: A review of nearly two decades in an autologous blood programme: The rise and fall of activity. Transfus Med 2006; 16:307-11.
11. Boulton FE, James V: Guidelines for policies on alternatives to allogeneic blood transfusion. 1. Predeposit autologous blood donation and transfusion. Transfus Med 2007; 17:354-65.
12. Horstmann WG, Ettema HB, Verheyen CC: Dutch orthopedic blood management surveys 2002 and 2007: An increasing use of blood-saving measures. Arch Orthop Trauma Surg 2009; 30:55-9.
13. Faris PM, Ritter MA, Abels RI: The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am 1996; 78:62-72.
14. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB: An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81:2-10.
15. Warner C: The use of the orthopaedic perioperative autotransfusion (OrthoPAT) system in total joint replacement surgery. Orthop Nurs 2001; 20:29-32.
16. Abuzakuk T, Senthil-Kumar V, Shenava Y, Bulstrode C, Skinner JA, Cannon SR, Briggs TW: Autotransfusion drains in total knee replacement. Are they alternatives to homologous transfusion? Int Orthop 2007; 31:235-9.
17. Adalberth G, Byström S, Kolstad K, Mallmin H, Milbrink J: Postoperative drainage of knee arthroplasty is not necessary: A randomized study of 90 patients. Acta Orthop Scand 1998; 69:475-8.
18. Amin A, Watson A, Mangwani J, Nawabi D, Ahluwalia R, Loeffler M: A prospective randomised controlled trial of autologous retransfusion in total knee replacement. J Bone Joint Surg Br 2008; 90:451-4.
19. Wood GC, Kapoor A, Javed A: Autologous drains in arthroplasty a randomized control trial. J Arthroplasty 2008; 23:808-13.
20. Rollo VJ, Hozack WJ, Rothman RH, Chao W, Eng KO: Prospective randomized evaluation of blood salvage techniques for primary total hip arthroplasty. J Arthroplasty 1995; 10:532-9.
21. So-Osman C, Nelissen RGHH, Koopman-van-Gemert AWMM, Kluyver TM, Pöll RG, Onstenk R, Van-Hilten JA, Jansen-Werkhoven TM, van-den-Hout WB, Brand R, Brand A: Patient blood management in elective total hip- And knee-replacement surgery (Part 2): A randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl. Anest hesiology 2014; 120:852-60.
22. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405:5-37.
23. So-Osman C, Nelissen RG, Eikenboom HC, Brand A: Efficacy, safety and user-friendliness of two devices for postoperative autologous shed red blood cell re-infusion in elective orthopaedic surgery patients: A randomized pilot study. Transfus Med 2006; 16:321-8.
24. So-Osman C, Nelissen R, Te-Slaa R, Coene L, Brand R, Brand A: A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cells. Vox Sang 2010; 98:56-64.
25. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR: Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50:753-65.
26. Zethraeus N, Johannesson M, Jönsson B, Löthgren M, Tambour M: Advantages of using the net-benefit approachfor analysing uncertainty in economic evaluation studies. Pharmacoeconomics 2003; 21:39-48.
27. Pocock SJ: When (not) to stop a clinical trial for benefit. JAMA 2005; 294:2228-30.
28. Alsaleh K, Alotaibi GS, Almodaimegh HS, Aleem AA, Kouroukis CT: The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: A meta-analysis of randomized clinical trials. J Arthroplasty 2013; 28:1463-72.
29. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL: Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHE O) study. Blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43:459-69.
30. Sehat KR, Evans RL, Newman JH: Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br 2004; 86:561-5.
31. Waters JH, Dyga RM, Waters JF, Yazer MH: The volume of returned red blood cells in a large blood salvage program: Where does it all go? Transfusion 2011; 51:2126-32.
32. SHOT Steering Group. SHOT Annual Report. 2010:pp 1-151.
33. Stowell CP, Jones SC, Enny C, Langholff W, Leitz G: An openlabel, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: Safety analysis. Spine 2009; 34:2479-85.
34. Vamvakas EC: Rationale for randomized controlled trials and for intention-to-treat analysis in transfusion medicine: Are they one and the same? Vox Sang 2008; 95:165-73.
35. Otten R, van-Roermund PM, Picavet HS: [Trends in the number of knee and hip arthroplasties: Considerably more knee and hip prostheses due to osteoarthritis in 2030]. Ned Tijdschr Geneeskd 2010; 154:A1534.
36. Gombotz H, Rehak PH, Shander A, Hofmann A: Blood use in elective surgery: The Austrian benchmark study. Transfusion 2007; 47:1468-80.
37. Goodnough LT, Maniatis A, Earnshaw P, Benoni G, Beris P, Bisbe E, Fergusson DA, Gombotz H, Habler O, Monk TG, Ozier Y, Slappendel R, Szpalski M: Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106:13-22.
38. Keating EM, Meding JB, Faris PM, Ritter MA: Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 1998; 357:50-9.
39. Spahn DR: Anemia and patient blood management in hip and knee surgery: A systematic review of the literature. Anesthesiology 2010; 113:482-95.